220 related articles for article (PubMed ID: 9553683)
1. Single dose study of the bioequivalence of two sustained-release theophylline formulations.
Contreras J; Pérez N; González R; Ontivero E; López M
Arzneimittelforschung; 1998 Mar; 48(3):259-62. PubMed ID: 9553683
[TBL] [Abstract][Full Text] [Related]
2. [In vivo verification of in vitro release specifications of a theophylline sustained-release preparation].
von Nieciecki A; Fuchs WS; Pabst G; Müller M; Dilger C; Gay S; Laicher A; Stanislaus F
Arzneimittelforschung; 1998 May; 48(5A):580-3. PubMed ID: 9676348
[TBL] [Abstract][Full Text] [Related]
3. [Absorption profile and absolute bioavailability of a theophylline sustained-release preparation].
Pabst G; Weber W; Barkworth MF; Müller M; Rehm KD
Arzneimittelforschung; 1998 May; 48(5A):574-9. PubMed ID: 9676347
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetics of a new fluid theophylline sustained-release drug form. Microcapsules in a sachet].
Fuchs WS; Weiss G; von Nieciecki A; Laicher A; Gay S; Pabst G; Müller M
Arzneimittelforschung; 1998 May; 48(5A):612-7. PubMed ID: 9676354
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacokinetics of a theophylline sustained-release formulation after single and twice daily dosage].
Fuchs WS; von Nieciecki A; Pabst G; Müller M; Dilger C; Gay S; Laicher A; Stanislaus F
Arzneimittelforschung; 1998 May; 48(5A):589-92. PubMed ID: 9676350
[TBL] [Abstract][Full Text] [Related]
6. Comparative bioavailability of two tablet formulations of ranitidine hydrochloride in healthy volunteers.
Bawazir SA; Gouda MW; El-Sayed YM; Al-Khamis KI; Al-Yamani MJ; Niazy EM; Al-Rashood KA
Int J Clin Pharmacol Ther; 1998 May; 36(5):270-4. PubMed ID: 9629991
[TBL] [Abstract][Full Text] [Related]
7. [The effect of food on theophylline absorption].
Pabst G; Weber W; Müller M; Barkworth MF
Arzneimittelforschung; 1998 May; 48(5A):569-73. PubMed ID: 9676346
[TBL] [Abstract][Full Text] [Related]
8. Relative bioavailability and bioequivalence study of theophylline sustained release formulations.
Vergin H; Mahr G; Winterhalter B; Wigand R
Arzneimittelforschung; 2003; 53(9):635-9. PubMed ID: 14558437
[TBL] [Abstract][Full Text] [Related]
9. Comparative bioavailability of two tablet formulations of acyclovir in healthy volunteers.
Al-Yamani MJ; Al-Khamis KI; El-Sayed YM; Bawazir SA; Al-Rashood KA; Gouda MW
Int J Clin Pharmacol Ther; 1998 Apr; 36(4):222-6. PubMed ID: 9587049
[TBL] [Abstract][Full Text] [Related]
10. Food interaction study of a new theophylline (Egifilin) 200 and 400 mg retard tablet in healthy volunteers.
Urmös I; Grézal G; Balogh Nemes K; Szállási T; Drabant S; Csörgo M; Klebovich I
Int J Clin Pharmacol Ther; 1997 Feb; 35(2):65-70. PubMed ID: 9147710
[TBL] [Abstract][Full Text] [Related]
11. Comparative bioavailability study on naproxen betainate sodium salt monohydrate and naproxen sodium salt in healthy volunteers.
Marzo A; Monti N; Ripamonti M; Marzo P; Wool C; Cerutti R; Maggi GC
Arzneimittelforschung; 1997 Apr; 47(4):385-9. PubMed ID: 9150858
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the bioequivalence of two faropenem formulations in healthy Indian subjects.
Bhaumik U; Ghosh A; Chakrabarty US; Mandal U; Bose A; Das A; Ray KK; Pal TK
Arzneimittelforschung; 2008; 58(12):681-5. PubMed ID: 19202741
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
14. Study on the absolute bioavailability of quinine and theophylline from tablets after single dose oral administration as compared to intravenous infusion in healthy male non-smoking volunteers.
Fuder H; Herzog R; Vaupel W; Wetzelsberger N; Lücker PW
Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):651-60. PubMed ID: 7746027
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the bioequivalence of zidovudine 100 mg capsules in healthy Thai male volunteers.
Chompootaweep S; Poonsrisawat J; Xumseang P
J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S79-85. PubMed ID: 17722305
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetics of theophylline in sustained-release formulation in young asthmatics].
Witschital K; Fuchs WS; Heese U; von Nieciecki A; Laicher A
Arzneimittelforschung; 1998 May; 48(5A):593-6. PubMed ID: 9676351
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets.
Gai MN; Isla A; Andonaegui MT; Thielemann AM; Seitz C
Int J Clin Pharmacol Ther; 1997 Dec; 35(12):565-71. PubMed ID: 9455715
[TBL] [Abstract][Full Text] [Related]
18. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
González MA; Straughan AB
Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
[TBL] [Abstract][Full Text] [Related]
20. [The pharmacokinetics and bioequivalence of acipimox sustained-release tablets after a single and multiple oral administration in healthy dogs].
Yang XG; Nie SF; Bai HJ; Zhang GJ; Pan WS
Yao Xue Xue Bao; 2005 May; 40(5):457-61. PubMed ID: 16220793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
